Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer

Abstract

Dose-escalated EBRT is associated with improved overall survival in men with intermediate- and high-risk prostate cancer but not low-risk prostate cancer. These results add to the evidence questioning aggressive local treatment strategies in men with low-risk prostate cancer but supporting such treatment in men with greater disease severity.